Education
About Us
Working with TipRanks
Follow Us
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
Earnings Data
Report Date
Dec 02, 2025Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
0.05Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with record-breaking metrics and significant market share growth in key regions and product categories. However, there are challenges in maintaining market share in certain regions and managing cash flow effectively.Company Guidance
Record-Breaking Financial Performance
Cannara achieved record revenue, gross profit, gross margin, operating income, and adjusted EBITDA in Q2 2025. Net revenues were CAD 26.6 million, up 6% quarter-over-quarter and 35% year-over-year. Adjusted EBITDA was CAD 7.1 million, up 18% quarter-over-quarter, representing over 100% year-over-year growth.
Strong Market Position in Quebec
Cannara holds a 12.8% market share in Quebec, up over 40% from the previous year. They are only 60 basis points from the number one spot, showing significant market share growth in their home province.
Leadership in Product Categories
Cannara leads the nationwide premium vape category with over 22% share and is the fastest-growing infused pre-roll multi-pack in Canada with a 10% market share. They have a commanding 73% share of infused pre-rolls in Quebec.
Cost Leadership and Operational Efficiency
Cannara maintains one of the lowest electricity rates in Canada, enabling cost-effective operations. They are expanding cultivation capacity by 20% with minimal capital outlay, showcasing strong operational efficiency.
LOVFF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LOVFF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 28, 2025 | $1.30 | $1.32 | +1.54% |
Apr 28, 2025 | $1.01 | $1.01 | 0.00% |
Jan 27, 2025 | $0.60 | $0.66 | +10.00% |
Nov 25, 2024 | $0.45 | $0.52 | +15.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cannara Biotech (LOVFF) report earnings?
Cannara Biotech (LOVFF) is schdueled to report earning on Dec 02, 2025, Before Open (Confirmed).
What is Cannara Biotech (LOVFF) earnings time?
Cannara Biotech (LOVFF) earnings time is at Dec 02, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LOVFF EPS forecast?
Currently, no data Available